Treatment of patients with a compressible attenuation device
Disclosed herein are methods of treating a patient, comprising providing a compressible attenuation device that is moveable from a first, introduction configuration to a second, implanted configuration. The attenuation device is introduced into a treatment site. In one embodiment, the treatment site is the bladder. In another embodiment, the treatment site is the abdominal cavity. The volume of the attenuation devices changes in response to pressure changes in the treatment site and attenuates pressure changes in the bladder.
1. A method of treating a patient, comprising the steps of:
providing a compressible attenuation device which is moveable from a first, introduction configuration to a second, implanted configuration;
introducing the attenuation device into the bladder while in the first configuration;
transforming the attenuation device within the bladder to the second configuration; and
attenuating a pressure change within the bladder by reversibly changing the volume of the attenuation device in response to the pressure change.
2. A method as in claim 1 , wherein the introducing step comprises transurethrally introducing the attenuation device into the bladder.
3. A method as in claim 1 , wherein the introducing step comprises placing the attenuation device percutaneously into the bladder.
4. A method as in claim 1 , wherein the transforming step comprises at least partially inflating the attenuation device.
5. A method as in claim 1 , wherein the transforming step comprises permitting the attenuation device to transform under its own bias.
6. A method as in claim 1 , wherein the transforming step minimizes pressure points in the bladder.
7. A method as in claim 1 , wherein the attenuating step comprises reducing the volume of the attenuation device by at least about 5%.
8. A method as in claim 1 , wherein the attenuating step comprises reducing the volume of the attenuation device by at least about 10%.
9. A method as in claim 1 , wherein the attenuating step comprises reducing the volume of the attenuation device by at least about 25%.
10. A method as it, claim 1 , wherein the attenuation of pressure changes within the bladder provides therapeutic benefits alter the attenuation device is removed.
11. A method as in claim 1 , wherein the compressible attenuation device is conformable to the shape of the bladder.
12. A method as in claim 1 , wherein the configuration of the attenuation device minimizes pressure points in the bladder.
13. A method of treating a patient, comprising the steps of:
providing a compressible attenuation device that is moveable from a first, introduction configuration to a second, implanted configuration;
introducing the attenuation device into a treatment site while in the first configuration;
transforming the attenuation device within the treatment site to the second configuration; and
attenuating a pressure change within the treatment site by reversibly changing the volume of the attenuation device in response to the pressure change.
14. A method as in claim 13 , wherein the treatment site comprises the bladder.
15. A method as in claim 14 , wherein the introducing step comprises transurethrally introducing the attenuation device into the bladder.
16. A method as in claim 14 , wherein the introducing step comprises placing the attenuation device percutaneously into the bladder.
17. A method as in claim 13 , wherein the treatment site comprises the abdominal cavity.
18. A method as in claim 13 , wherein the treatment site comprises the bladder wall.
19. A method as in claim 13 , wherein the transforming step comprises at least partially inflating the attenuation device.
20. A method as in claim 13 , wherein the transforming step comprises permitting the attenuation device to transform under its own bias.
21. A method as in claim 13 , wherein the attenuating step comprises reducing the volume of the attenuation device by at least about 5%.
22. A method as in claim 13 , wherein the attenuating step comprises reducing the volume of the attenuation device by at least about 10%.
23. A method as in claim 13 , wherein the attenuating step comprises reducing the volume of the attenuation device by at least about 25%.
24. A method as in claim 14 , wherein the attenuation of pressure changes within the bladder provides therapeutic benefits after the attenuation device is removed.
25. A method as in claim 14 , wherein the compressible attenuation device is conformable to the shape of the bladder.
26. A method as in claim 17 , wherein the compressible attenuation device is conformable to the shape of the abdominal cavity.
27. A method as in claim 18 , wherein the compressible attenuation device is conformable to the shape of the bladder wall.
28. A method as in claim 13 , wherein the introducing step comprises introducing the attenuation device into a radical prostatectomy patient.
29. A method of implanting a compressible attenuation device, comprising the steps of:
providing the attenuation device, the device being moveable from a first, introduction configuration to a second, implanted configuration;
introducing the attenuation device into a treatment site while in the first configuration; and
transforming the attenuation device within the treatment site to the second configuration.
30. A method as in claim 29 , wherein the treatment site comprises the bladder.
31. A method as in claim 30 , wherein the introducing step comprises transurethrally introducing the attenuation device into the bladder.
32. A method as in claim 30 , wherein the introducing step comprises placing the attenuation device percutaneously into the bladder.
33. A method as in claim 29 , wherein the treatment site comprises the abdominal cavity.
34. A method as in claim 29 , wherein the treatment site comprises the bladder wall.
35. A method as in claim 29 , wherein the transforming step comprises at least partially inflating the attenuation device.
36. A method as in claim 29 , wherein the transforming step comprises permitting the attenuation device to transform under its own bias.
37. A method as in claim 30 , wherein the compressible attenuation device is conformable to the shape of the bladder.
38. A method as in claim 33 , wherein the compressible attenuation device is conformable to the shape of the abdominal cavity.
39. A method as in claim 34 , wherein the compressible attenuation device is conformable to the shape of the bladder wail.
40. A method as in claim 29 , wherein the introducing step comprises introducing the attenuation device into a radical prostatectomy patient.